急性骨髄性白血病患者の薬剤応答に対する堅牢な予測因子
1Institute for Systems Biology, Seattle, Washington, United States of America.
Abstract:
The significant heterogeneity in treatment responses among patients with acute myeloid leukemia (AML) underscores the critical need for accurate drug response prediction. We developed k-Top Scoring Pairs (kTSP) classifiers, ensemble methods that aggregate the relative expression of gene pairs. We compared their accuracy with that of state-of-the-art machine learning methods, linear and radial basis function support vector machines, random forest and elastic net regression classifiers for drug response prediction of patients with AML. Our results demonstrate that kTSP particularly outperforms other methods when the number of sensitive and resistant patients is imbalanced, a common challenge in clinical studies. Our approach is inherently robust to batch effects and uniquely suited for single-patient classification due to its rank-based methodology.
さらに関連する動画
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
関連する概念動画
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Factors Affecting Drug Response: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
